Mnexspike Injection, Suspension
Product Images NDC 80777-400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mnexspike (NDC 80777-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Moderna Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mnexspike (covid-19 Vaccine, Mrna) 2025-2026 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe 0.2 mL (Image 01)

Mnexspike (covid-19 Vaccine, Mrna) 2025-2026 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe 0.2 mL (Image 01)
This text mentions NEXSPIKEâ„¢ as a formula for the 2025-2026 period. It appears to be related to the COVID-19 Vaccine, particularly the mRNA vaccine. The NDC number 80777-4 may be associated with this product.*
FDA Label Image

Mnexspike (covid-19 Vaccine, Mrna) 2025-2026 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe Carton 0.2 mL (80777-400-60) (Image 02)

FDA Label Image

Mnexspike (covid-19 Vaccine, Mrna) 2025-2026 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe Carton 0.2 mL (80777-400-61) (Image 03)

FDA Label Image

Mnexspike (covid-19 Vaccine, Mrna) 2025-2026 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe Carton 0.2 mL (80777-400-62) (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.